What is the workup for a suspected pulmonary embolism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Pulmonary Embolism

Begin by stratifying clinical probability using a validated prediction rule (Wells or revised Geneva score), then proceed with D-dimer testing in low/intermediate probability patients or direct imaging in high-risk patients—never order D-dimer in hemodynamically unstable patients or those with high clinical probability. 1

Initial Assessment and Risk Stratification

Hemodynamic Status (First Priority)

  • Immediately assess for shock or hypotension (systolic BP <90 mmHg or drop ≥40 mmHg for >15 minutes) to identify high-risk PE requiring emergent management 1
  • In hemodynamically unstable patients, perform bedside echocardiography or emergency CTPA depending on availability—initiate IV unfractionated heparin with weight-adjusted bolus (80 units/kg) without delay 1, 2
  • Massive PE is highly likely when patients present with collapse, unexplained hypoxia, engorged neck veins, or right ventricular gallop 2

Clinical Probability Assessment (Stable Patients)

  • Use Wells score or revised Geneva score to categorize patients into low, intermediate, or high clinical probability 1
  • Wells score assigns points for: active cancer (+1), paralysis/recent immobilization (+1), bedridden >3 days or major surgery within 4 weeks (+1.5), localized leg tenderness (+1), entire leg swelling (+1), calf swelling >3 cm (+1), pitting edema (+1), collateral superficial veins (+1), previous PE/DVT (+1.5), heart rate >100 (+1.5), hemoptysis (+1), and PE as likely or more likely than alternative diagnosis (+3) 1
  • Revised Geneva score includes: previous PE/DVT (+3), heart rate 75-94 (+3) or ≥95 (+5), surgery or fracture within past month (+2), hemoptysis (+2), active cancer (+2), unilateral leg pain (+3), and pain on deep venous palpation/unilateral edema (+4) 1, 2
  • Document respiratory rate in all patients—tachypnea >20 breaths/min is present in most PE cases and significantly raises probability 2, 3

Diagnostic Algorithm by Clinical Probability

Low Clinical Probability

  • Apply PERC (Pulmonary Embolism Rule-Out Criteria) first in low-risk patients: if all 8 criteria are met (age <50, pulse <100, SaO₂ ≥95%, no hemoptysis, no estrogen use, no prior DVT/PE, no unilateral leg swelling, no surgery/trauma requiring hospitalization within 4 weeks), the risk of PE is lower than testing risks—stop workup 1
  • If PERC criteria not met, order highly sensitive D-dimer (preferably Vidas ELISA or equivalent) 1
  • D-dimer <500 ng/mL (or age-adjusted: age × 10 ng/mL for patients >50 years) safely excludes PE—no imaging needed, with 3-month thromboembolic risk <1% 1, 2, 4
  • If D-dimer elevated, proceed to CTPA 1

Intermediate Clinical Probability

  • Order D-dimer testing (do not use PERC criteria in this group) 1
  • D-dimer <500 ng/mL (or age-adjusted) excludes PE—no imaging required 1
  • If D-dimer elevated, proceed to CTPA 1
  • Initiate therapeutic anticoagulation immediately while awaiting imaging results 1, 2

High Clinical Probability

  • Proceed directly to CTPA without D-dimer testing—negative D-dimer does not safely exclude PE in this population 1
  • Initiate therapeutic anticoagulation immediately before imaging confirmation 1, 2

Imaging Studies

CT Pulmonary Angiography (CTPA)

  • CTPA is the first-line imaging modality for hemodynamically stable patients 1
  • A normal CTPA in patients with low or intermediate clinical probability definitively excludes PE—no further testing needed 1
  • CTPA showing segmental or more proximal filling defect in intermediate/high probability patients confirms PE 1
  • In high clinical probability patients with negative CTPA, consider additional testing (leg ultrasound or pulmonary angiography) or specialist consultation 2

Ventilation-Perfusion (V/Q) Scanning

  • Use V/Q scan when CTPA is contraindicated (renal failure, contrast allergy, pregnancy) or unavailable 1
  • V/Q scan is preferred in younger patients and pregnant women to minimize radiation exposure, particularly breast tissue 1
  • Normal perfusion scan excludes PE 1
  • High-probability scan with high clinical probability confirms PE 1, 2
  • Low-probability scan with low clinical probability excludes PE 2
  • All other combinations require CTPA or pulmonary angiography for definitive diagnosis 1, 2
  • V/Q scanning should only be used when chest X-ray is normal and patient has no significant cardiopulmonary disease—otherwise results are likely non-diagnostic 2

Lower Extremity Compression Ultrasound

  • Perform CUS before CT imaging in patients with clinical signs of DVT, renal failure, contrast allergy, or pregnancy 1, 2
  • Proximal DVT on ultrasound confirms VTE—treat with anticoagulation without further pulmonary imaging 1
  • Normal ultrasound does not exclude PE (only 30-50% of PE patients have detectable DVT)—proceed to lung imaging if D-dimer elevated 1, 2

Critical Pitfalls to Avoid

  • Never order D-dimer in high clinical probability patients—sensitivity is too low and negative result will not obviate need for imaging 1
  • Never order D-dimer in hospitalized patients with infection, cancer, inflammation, or recent surgery—false-positive rates exceed 90%, making the test clinically useless 2, 5
  • Do not use D-dimer as a standalone test—always combine with validated clinical probability assessment 1, 5
  • Never rely on normal oxygen saturation to exclude PE—up to 40% of PE patients have normal SaO₂ 2, 3
  • Do not perform CT venography as adjunct to CTPA—adds no diagnostic value 1
  • Do not use MRA to rule out PE—insufficient validation 1
  • Never use positive D-dimer alone to diagnose PE—confirmation with imaging is always required due to poor specificity (35%) 5

Timing of Diagnostic Testing

  • Imaging for massive PE must be performed within 1 hour of presentation 2
  • Imaging for non-massive PE should be completed within 24 hours of clinical suspicion 2, 3
  • If imaging cannot be obtained within 24 hours in intermediate/high probability patients, continue therapeutic anticoagulation until imaging is available 2

Special Populations

Pregnancy

  • Use V/Q scan or CTPA (both safe during pregnancy)—V/Q scan preferred by many to minimize fetal radiation 1
  • Consider lower extremity ultrasound first to avoid any radiation if DVT can be confirmed 1
  • NOACs are contraindicated in pregnancy—use LMWH or unfractionated heparin 1

Cancer Patients

  • D-dimer has limited utility due to high false-positive rates 2, 5
  • Proceed directly to imaging based on clinical probability 3
  • Markedly elevated D-dimer (>5000 μg/L) may indicate occult malignancy in 29% of cases 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pulmonary Embolism Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosis and Management of Pulmonary Embolism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

D-Dimer Testing in Suspected Deep Vein Thrombosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the recommended approach to diagnose and treat pulmonary embolism, including risk assessment, imaging, anticoagulation, thrombolysis, IVC filter placement, and duration of therapy?
What is the role of D-dimer (D-dimer) testing in the diagnosis and management of pulmonary thromboembolism?
What is the best initial test to rule out pulmonary embolism in a patient with chest pain and a history of coronary artery disease?
In the scenario of pulmonary embolism, which is the most sensitive investigation?
In a patient presenting with chest pain, should I obtain a D‑dimer to evaluate for pulmonary embolism?
In a 60‑year‑old woman with triple‑negative, high‑grade invasive ductal carcinoma who received neoadjuvant doxorubicin‑cyclophosphamide, paclitaxel, carboplatin and pembrolizumab, then underwent mastectomy with sentinel‑node biopsy showing an 8 mm residual primary tumor (ypT1c) and no nodal disease, but had an initially clinically positive 11 mm axillary lymph node that was not biopsied before systemic therapy, should she receive adjuvant chest‑wall and regional nodal radiotherapy?
Is nasal saline safe for a healthy adult without hypertension, coronary artery disease, arrhythmia, hyperthyroidism, glaucoma, or recent MAOI (monoamine oxidase inhibitor) use, and can it be combined with oral pseudoephedrine and intranasal oxymetazoline for flight‑related nasal decongestion?
What are the differences between hemodialysis and peritoneal dialysis?
How does mild concentric left‑ventricular hypertrophy contribute to end‑organ damage in a patient with chronic diastolic dysfunction, low end‑diastolic volume, low stroke‑volume index, and heart‑failure with preserved ejection fraction physiology?
In a patient with congestive heart failure on furosemide (Lasix), should potassium be given concurrently to prevent hypokalemia?
What is the best overall treatment for amyotrophic lateral sclerosis in a patient with early-stage disease (symptom onset ≤ 2 years, preserved respiratory function, no severe bulbar involvement)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.